QoL summary score
|
β coefficient (95 % CI)
|
β coefficient (95 % CI)
|
---|
OR (95 % CI)
|
OR (95 % CI)
|
---|
unadjusted
|
Adjusted
|
---|
PHS
| | |
CD4 count <100 cells/μl
| | |
NVP
|
Ref
|
Ref
|
EFV
|
−1.61(−2.82 to −0.40)
|
−1.61 (−2.74 to −0.49)a
|
P = 0.11d
|
CD4 count 101–250 cells/μl
| | |
NVP
|
Ref
|
Ref
|
EFV
|
0.17 (−0.70 to 1.05)
|
0.82 (0.22 to 1.43)a
|
P = 0.76d
|
CD4 count >250 cells/μl
| | |
NVP
|
Ref
|
Ref
|
EFV
|
0.97 (−0.35 to 2.30)
|
−1.33 (−5.66 to 3.00)a
|
P = 0.90d
|
MHS
| | |
CD4 count <100 cells/μl
| | |
NVP
|
Ref
|
Ref
|
EFV
|
−0.18 (−1.18 to 0.82)
|
−0.39 (−1.40 to 0.62)b
|
P = 0.91d
|
CD4 count 101–250 cells/μl
| | |
NVP
|
Ref
| |
EFV
|
−0.09 (−0.93 to 0.75)
|
0.16 (−0.66 to 0.98)b
|
P = 0.78d
|
CD4 count >250 cells/μl
| | |
NVP
|
Ref
|
Ref
|
EFV
|
−0.84 (−2.09 to 0.42)
|
−0.75 (−2.01 to 0.51)b
|
P = 0.65d
|
GPGI
| | |
CD4 count <100 cells/μlEFV versus NVP
| | |
|
−0.59 (0.31 to 1.13)
|
0.51 (0.25 to1.04)c
|
P = 0.54d
|
CD4 count 101–250 cells/μl
| | |
EFV versus NVP
|
0.85 (0.54 to 1.33)
|
0.98 (0.60 to 1.56)c
|
P = 0.08d
|
CD4 count >250 cells/μl
| | |
EFV versus NVP
|
1.30 (0.66 to 2.56)
|
1.39 (0.66 to 2.90)c
|
P = 0.08d
|
- aadjusted for age, study visit, diagnosis of depression, income per month, WHO stage, education level and opportunistic infection
- badjusted for sex, age, study visit, WHO stage, marital status, social support and level of education
- cadjusted for sex, age, study visit, WHO stage, education level, income per month, depression, employment status, alcohol use, social support and opportunistic infection
- dP value for interaction term (time*ART regimen)